亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Methods For Diagnostic Techniques And Diagnosis Of Multiple Sclerosis, Autoimmune Disorders And Diseases Related To Glycan Dysregulation

技术优势: Versatile diagnostic and monitoring method: § Can be applied to many types of glycan-related diseases and disorders to identify and quantify biomarkers § Can monitor treatments that include the described and related metabolites as medications Efficient and accessible: -The approach is simple, easy to perform, and produces results rapidly -Utilizes common lab instrumentation, liquid chromatography-mass spectrometry

技术应用: .Diagnose, identify and analyze diseases associated with glycan dysregulation: Multiple Sclerosis, Type I and Type II Diabetes, Cancer .Utilize methods in a clinical setting to determine disease status and efficiency of therapeutics .Guide treatment options and strategies .Monitor therapies and medications

详细技术说明: Multiple Sclerosis (MS) is a highly prevalent autoimmune disorder, affecting 400,000 people per year in the US. There is no specific test for MS, thus it is typically diagnosed by ruling out other diseases and disorders using an array of tests, including expensive or invasive procedures, such as brain imaging and lumbar punctures. Researchers at UCI have determined that specific metabolites that are present in healthy human serum and influence protein glycosylation, including Uridine and G1cNAc, are deficient in individuals with MS, leading to dysregulation of glycosylation. They have developed a mass spectroscopy assay to be used as a novel diagnostic test for Multiple Sclerosis. The technique assesses the composition of human serum for key metabolites associated with the disease. Unlike other diagnostic methods, this assay is noninvasive, quantitative, and highly sensitive. Furthermore, this research and assay may be applicable for the diagnosis or prevention of related disorders with underlying defective protein glycosylation.

*Abstract: Certain diseases, such as Multiple Sclerosis and other autoimmune disorders, are associated with deficiencies in specific metabolites that influence protein glycosylation. This invention is a specialized method to detect levels of these metabolites, which can then be used to diagnose disorders and guide personalized treatments.

*Principal Investigation: Name: Micheal Demetriou
Department:

Name: James Dennis
Department:

Name: Alexander Brandt
Department:

Name: Paul Friedmann
Department:

欲了解更多信息，请点击这里